Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology.
Commun Med (Lond)
; 2(1): 154, 2022 Dec 06.
Article
in En
| MEDLINE
| ID: mdl-36473994
Drug development is lengthy and costly, as it relies on laboratory models that fail to predict human reactions to potential drugs. Because of this, toxic drugs sometimes go on to harm humans when they reach clinical trials or once they are in the marketplace. Organ-on-a-Chip technology involves growing cells on small devices to mimic organs of the body, such as the liver. Organ-Chips could potentially help identify toxicities earlier, but there is limited research into how well they predict these effects compared to conventional models. In this study, we analyzed 870 Liver-Chips to determine how well they predict drug-induced liver injury, a common cause of drug failure, and found that Liver-Chips outperformed conventional models. These results suggest that widespread acceptance of Organ-Chips could decrease drug attrition, help minimize harm to patients, and generate billions in revenue for the pharmaceutical industry.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
/
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Commun Med (Lond)
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: